Week Ending May 31, 2022

Alabama Medicaid Under Fire for Denying Drug Users Hep C Cure
“On May 9, the Center for Health Law and Policy Innovation (CHLPI) and AIDS Alabama filed an administrative complaint with the United States Department of Justice (DOJ), alleging that Alabama Medicaid is illegally discriminating against people with substance use disorder by obstructing access to treatment for hepatitis C.”

Pharmacists Can Identify, Prevent, and Treat Viral Hepatitis
“Hepatitis is a disease characterized by liver inflammation, with hepatitis A, B, and C being the 3 most common viral hepatitis types in the United States.”

Hepatitis C Treatment Costs: What to Expect
“Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). For some people, HCV infection only causes short-term illness. However, for more than half who become infected, HCV can become a chronic infection that leads to liver injury and even death if left untreated.”

Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy
“The goal of hepatitis C virus (HCV) treatment is to cure the patient of the infection, defined as a nondetectable HCV RNA at least 12 weeks after treatment completion, or sustained virologic response (SVR). The COVID-19 pandemic has presented new barriers to care in the treatment of patients with HCV that resulted in a transition to tele-health services at many health systems to overcome these barriers.”

Child Hepatitis: What to Know About Cases of Liver Damage in Kids
“Older cases of pediatric hepatitis have been reported, adding to the CDC’s investigation of illness in otherwise healthy children.”

State announces plan to eliminate hepatitis C in Missouri
“The “Show Me the Cure” plan is intended to improve access to testing and patient-centered treatment services to combat the hepatitis C virus, according to a news release.”